Beijing, China

Jie Ding

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Kyland Technology Co., Ltd., Nantong Biotechnology Park Development and Investment Co., Ltd.. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jie Ding. Retrieved from https://idiyas.com/inventor/jie-ding-fgepmd2v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jie Ding - Innovator in Data Transmission and Immunotherapy

Introduction

Jie Ding is a prominent inventor based in Beijing, China. He has made significant contributions to the fields of data transmission and immunotherapy, holding a total of 2 patents. His innovative approaches address critical challenges in network efficiency and cancer treatment.

Latest Patents

One of Jie Ding's latest patents is a time-triggered Ethernet-based data transmission method and node device. This invention solves the problem of wasting network bandwidth resources during TTE-based data transmission. The method involves a main node determining a scheduling period table based on a time-triggered packet. When a node has an event-triggered packet to transmit, it can do so in the current time slot if there is no conflict with the physical link. This effectively improves data transmission efficiency and network bandwidth utilization.

Another significant patent involves methods for the proliferation of antigen-specific T cells. This method includes generating antigen-specific T cells by stimulating them with antigen A. It also introduces genes encoding immune recognition molecules specific to major histocompatibility complex (MHC) molecules bound with peptides derived from antigen B. This innovation allows for the expansion of bi-specific T cells that can recognize target cells expressing both antigen A and antigen B, providing a potential therapeutic approach for cancer treatment.

Career Highlights

Jie Ding has worked with notable companies such as Kyland Technology Co., Ltd. and Nantong Biotechnology Park Development and Investment Co., Ltd. His experience in these organizations has contributed to his expertise in technology and biotechnology.

Collaborations

Throughout his career, Jie Ding has collaborated with talented individuals, including Huayi Ma and Baihua Xue. These collaborations have likely enriched his research and development efforts.

Conclusion

Jie Ding's innovative work in data transmission and immunotherapy showcases his commitment to advancing technology and healthcare solutions. His patents reflect a deep understanding of complex systems and a drive to improve efficiency and effectiveness in critical areas.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…